4//SEC Filing
Kender Richard N 4
Accession 0000950170-24-076260
CIK 0001850838other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:20 PM ET
Size
5.4 KB
Accession
0000950170-24-076260
Insider Transaction Report
Form 4
Kender Richard N
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-20+50,000→ 50,000 totalExercise: $2.20Exp: 2034-06-19→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in thirty-six substantially equal monthly installments following the date of grant, such that the option shall be fully vested and exercisable on the third anniversary of the date of grant, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such vesting date.
Documents
Issuer
Omega Therapeutics, Inc.
CIK 0001850838
Entity typeother
Related Parties
1- filerCIK 0001381205
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 4:20 PM ET
- Size
- 5.4 KB